-
National estimates of contraceptive use and method choice from the most recent 2006-2008 cycle of the National Surveys of Family Growth (NSFG) were compared to earlier estimates based on the 1982, 1995, and 2002 surveys.
-
In 1972, liggins and howie demonstrated that antenatal corticosteroids (ACS) stimulated the production of surfactant in premature human fetuses.
-
The primary purpose of this study was to develop a gene expression profile of BRCA dysfunction ("BRCAness"), which could be used to discriminate sporadic ovarian cancer patients with or without dysfunction to the homologous repair pathway and correlate whether this profile would describe sensitivity to platinum-based chemotherapy and pharmacological inhibition of poly-ADP ribose polymerase (PARP).
-
The U.S. medical eligibility criteria for contraceptive Use is a newly available, free, evidence-based resource for clinicians. This resource provides guidance to aid contraceptive decision-making for women (and men) with comorbidities.
-
Yes, we've all heard this tongue-in-cheek summary of why surgery is used to determine what is wrong with a patient. Supposedly, an operation gets to the patient's underlying problem. The message is not subtle.
-
-
In this issue: New reports about proton pump inhibitors and the effects of gastric suppression, pioglitazone vs vitamin E for non-alcoholic steatohepatitis, metformin and vitamin B12 deficiency, and FDA Actions.
-
The purpose of this study was to estimate the association between antibacterial medications and selected birth defects.
-
This spring a consensus opinion appears in the journal Diabetes Care, which represented a summary of deliberations of the International Association of Diabetes in Pregnancy Study Groups (IADPSG), a collaboration of 225 experts in the field from 40 countries, who gathered in Pasadena, CA, in June 2008. Since the current screening protocol for gestational diabetes (GDM) is about 40 years old, the group's goal was to make recommendations based on the best up-to-date information.
-
Lung cancer is the leading cause of cancer-related mortality among women. To investigate the potential role of hormone replacement therapy (HRT) in lung cancer development, the authors evaluated a prospective cohort of 36,588 peri- and postmenopausal women aged 50-76 years from Washington State recruited in 2000-2002 as part of the Vitamins and Lifestyle (VITAL) Study.
